![Lian Yong Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lian Yong Chen
Président chez
OCUMENSION THERAPEUTICS
Profil
Lian Yong Chen was the founder of Frontline Bioventures, established in 2012, and served as Managing Partner from 2012 to 2017.
Dr. Chen is the founder of 6 Dimensions Capital, serving as CEO & Founding Partner since 2017.
Current positions include Chairman at Tongrun Biomedicine (Shanghai) Co., Ltd. since 2018; Non-Executive Chairman at Ocumension Therapeutics since 2021; Chairman at Cutia Therapeutics (Shanghai) Co., Ltd.; Non-Executive Chairman at Cutia Therapeutics since 2022; Non-Executive Director at Neusoft Medical Systems Co., Ltd. since 2021; Director at Engine Biosciences Pte Ltd.; Director at Hua Medicine Technology (Hong Kong) Ltd. since 2015; Director at Hua Medicine (Shanghai) Co., Ltd. since 2016; and General Partner at China Life Sciences Access Fund LP.
Former positions include Director at Shanghai Hile Bio-Technology Co., Ltd. from 2014 to 2017; Non-Executive Director at Hua Medicine Ltd. from 2015 to 2022; Director at Innovent Biologics, Inc.; Director at Adagene, Inc.; Director at Parabilis Medicines, Inc.; Non-Executive Director at CStone Pharmaceuticals Co. Ltd. from 2018 to 2021; Non-Executive Director at Xikang Cloud Hospital Holdings, Inc. from 2019 to 2025; Director at TenNor Therapeutics Suzhou Ltd.; Director at 111, Inc. from 2019 to 2024; Director at Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. from 2019 to 2021; and Partner at FIL Capital Management (Hong Kong) Ltd. from 2008 to 2014.
Education includes an undergraduate degree from Peking University conferred in 1984 and a doctorate from Université Catholique de Louvain conferred in 1991.
Postes actifs de Lian Yong Chen
| Sociétés | Poste | Début |
|---|---|---|
| CUTIA THERAPEUTICS | Président | 23/08/2019 |
| OCUMENSION THERAPEUTICS | Président | 20/07/2021 |
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in drug development | Directeur/Membre du Conseil | 01/04/2016 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Président | - |
Neusoft Medical Systems Co., Ltd.
 Neusoft Medical Systems Co., Ltd. Medical SpecialtiesHealth Technology Manufactures medical imaging equipment | Directeur/Membre du Conseil | 28/03/2019 |
China Life Sciences Access Fund LP
 China Life Sciences Access Fund LP Investment ManagersFinance Functions as venture capital fund | Corporate Officer/Principal | - |
Hua Medicine Technology (Hong Kong) Ltd. | Directeur/Membre du Conseil | 01/01/2015 |
Engine Biosciences Pte Ltd.
 Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes | Directeur/Membre du Conseil | - |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Directeur Général | 18/05/2017 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Lian Yong Chen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Lian Yong Chen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
China Life Sciences Access Fund LP
China Life Sciences Access Fund LP Investment ManagersFinance Functions as venture capital fund | Finance |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neusoft Medical Systems Co., Ltd.
Neusoft Medical Systems Co., Ltd. Medical SpecialtiesHealth Technology Manufactures medical imaging equipment | Health Technology |
Shanghai Hile Bio-Technology Co., Ltd.
 Shanghai Hile Bio-Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Specializes in sales, marketing and commercialization of animal vaccine products | Health Technology |
Hua Medicine Ltd.
 Hua Medicine Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for diabetes and Central Nervous System disorders | Health Technology |
Innovent Biologics, Inc.
 Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Frontline Bioventures
 Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Finance |
Xikang Cloud Hospital Holdings, Inc.
 Xikang Cloud Hospital Holdings, Inc. Data Processing ServicesTechnology Services Provides cloud medical and health management services | Technology Services |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which engages in discovery, development and commercialization of therapies for bacterial infections and metabolism | Health Technology |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
Engine Biosciences Pte Ltd.
Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes | Health Technology |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Tongrun Biomedicine (Shanghai) Co., Ltd.
 Tongrun Biomedicine (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops tumor immunotherapy drugs | Health Technology |
111, Inc.
 111, Inc. Medical DistributorsDistribution Services Operates as holding company whose subsidiaries wholesales and retails pharmaceuticals | Distribution Services |
Hua Medicine Technology (Hong Kong) Ltd. | |
Hua Medicine (Shanghai) Co., Ltd.
Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in drug development | Health Technology |
FIL Capital Management (Hong Kong) Ltd.
 FIL Capital Management (Hong Kong) Ltd. Investment ManagersFinance Operates as a investment management firm | Finance |
Ocumension Therapeutics
 Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
 Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
